Key facts
- This page summarizes Stuart D. Porter's Form 4 filing for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Jun 2026, 16:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Represents a grant of 25,000 restricted share units ("RSUs"). The RSUs were granted pursuant to the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting, subject to continued service. The RSUs shall vest 25% on May 29, 2026, and 25% on the last date of each subsequent calendar quarter thereafter until fully vested.